Pfizer ends global development of Beqvez gene therapy
-- Pfizer (NYSE:PFE), the pharmaceutical giant, has decided to discontinue the global development and commercialization of its gene therapy product, Beqvez, used...
-- Pfizer (NYSE:PFE), the pharmaceutical giant, has decided to discontinue the global development and commercialization of its gene therapy product, Beqvez, used...
-- Shares of Dollar Tree (NASDAQ:DLTR) ticked up 0.8% following reports from Reuters that buyout firms, including Apollo Global Management (NYSE:APO) and Sycamore...
-- Shares of Valaris Limited (NYSE: VAL) climbed 4% following the offshore drilling company's fourth-quarter earnings report, which surpassed Wall Street's...
-- The Federal Reserve's highest-ranking regulatory official has issued a warning against the potential softening of bank regulations and oversight. The official...
By Abigail Summerville NEW YORK (Reuters) - Private equity firms Apollo Global Management (NYSE:APO) and Sycamore Partners are among the bidders who are competing to acquire...
-- The U.S. Securities and Exchange Commission (SEC) has opted to withdraw its appeal of a federal judge's decision from late last year, which annulled a revision of...
By Nate Raymond (NSE:RYMD) (Reuters) -Several Venezuelans and three immigrant rights groups have sued President Donald Trump's administration over its decision to end temporary...
By Alun John and Naomi Rovnick LONDON (Reuters) - The outsized swings in markets on the back of Donald Trump's every word on tariffs just weeks ago have faded to mere flickers, as...
By Allison Lampert, Abhijith Ganapavaram and David Shepardson (Reuters) - Boeing (NYSE:BA) CEO Kelly Ortberg on Thursday said Elon Musk, the head of its space business rival...
Thursday's market has witnessed notable fluctuations among stocks, with significant movements particularly observed in the mega-cap and large-cap categories. Stocks such as...